737
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Ulipristal acetate and its role in emergency contraception: a comment

, MD PhD
Pages 1821-1823 | Published online: 08 Aug 2012

Bibliography

  • Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N Engl J Med 1995;333(23):1517-21
  • Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. FFPRHC Guidance (April 2006). Emergency contraception. J Fam Plann Reprod Health Care 2006;32(2):121-8
  • Yuzpe AA, Thurlow HJ, Ramzy I, Post coital contraception – a pilot study. J Reprod Med 1974;13(2):53-8
  • Stratton P, Hartog B, Hajizadeh N, A single midfollicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women. Hum Reprod 2000;15(5):1092-9
  • Martinez AM, Thomas AM. Ulipristal acetate as an emergency contraceptive agent. Expert Opin Pharmacother 2012 July 7. [Epub ahead of print]
  • US Food and Drug Administration. Ulipristal acetate: new drug review appplication 22 – 474. Cent Drug Eval Res 2009
  • Glasier AF, Cameron ST, Fine PM, Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet 2010;375(9714):555-62
  • Creinin MD, Schlaff W, Archer DF, Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol 2006;108(5):1089-97
  • Fine P, Mathe H, Ginde S, Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception. Obstet Gynecol 2010;115(2 Pt 1):257-63
  • Richardson AR, Maltz FN. Ulipristal acetate: review of the efficacy and safety of a newly approved agent for emergency contraception. Clin Ther 2012;34(1):24-36.
  • Bouchard P, Chabbert-Buffet N, Fauser BC. Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety. Fertil Steril 2011;96(5):1175-89
  • Ioffe OB, Zaino RJ, Mutter GL. Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator. Mod Pathol 2009;22(3):450-9
  • Donnez J, Tomaszewski J, Vázquez F, Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med 2012;366(5):421-32
  • Donnez J, Tatarchuk TF, Bouchard P, Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 2012;366(5):409-20

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.